Publications

Filters: Keyword is Dog Diseases  [Clear All Filters]
1996
Teifke JP, Löhr CV.  1996.  Immunohistochemical detection of P53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs.. Journal of comparative pathology. 114(2):205-10. Abstract
1995
Vail DM, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Kisseberth WC, London CA, Obradovich JE, Madewell BR, Rodriguez CO.  1995.  Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(10):1165-70. Abstract
Kisseberth WC, MacEwen EG, Helfand SC, Vail DM, London CL, Keller E.  1995.  Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma.. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 9(6):425-8.
Helfand SC, Modiano JF, Moore PF, Soergel SA, MacWilliams PS, Dubielzig RD, Hank JA, Gelfand EW, Sondel PM.  1995.  Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphoma.. Blood. 86(2):636-45. Abstract
Kurzman ID, MacEwen EG, Rosenthal RC, Fox LE, Keller ET, Helfand SC, Vail DM, Dubielzig RR, Madewell BR, Rodriguez CO.  1995.  Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(12):1595-601. Abstract
1994
Helfand SC, Soergel SA, Donner RL, Gan J, Hank JA, Lindstrom MJ, Sondel PM.  1994.  Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy model.. Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy. 16(3):188-97. Abstract
Jackson MW, Helfand SC, Smedes SL, Bradley GA, Schultz RD.  1994.  Primary IgG secreting plasma cell tumor in the gastrointestinal tract of a dog.. Journal of the American Veterinary Medical Association. 204(3):404-6. Abstract
Helfand SC, Soergel SA, Modiano JF, Hank JA, Sondel PM.  1994.  Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro.. Cancer biotherapy. 9(3):237-44. Abstract
1993
Keller ET, MacEwen EG, Rosenthal RC, Helfand SC, Fox LE.  1993.  Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma.. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 7(5):289-95. Abstract
Sorenmo KU, Jeglum KA, Helfand SC.  1993.  Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide.. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 7(6):370-6. Abstract